
Yuqi Yang
Articles
-
2 months ago |
nature.com | Yuqi Yang
AbstractBesides the important pathogenic mechanisms of melanoma, including BRAF-driven and immunosuppressive microenvironment, genomic instability and abnormal DNA double-strand breaks (DSB) repair are significant driving forces for its occurrence and development. This suggests investigating novel therapeutic strategies from the synthetic lethality perspective. Poly (ADP-ribose) polymerase 4 (PARP4) is known to be a member of the PARP protein family.
-
Jun 18, 2024 |
onlinelibrary.wiley.com | Yuqi Yang |Jun Ge |Xiaoyan Zhong |Luyao Liu
Currently, sonodynamic therapy (SDT) has limited therapeutic outcomes and immune responses, highlighting the urgent need for enhanced strategies that can stimulate robust and long-lasting antitumor effects. Microcystis, a notorious microalga, reveals the possibility of mediating SDT owing to the presence of gas vesicles (GVs) and phycocyanin (PC).
-
Jan 24, 2024 |
dx.doi.org | Gang Wang |Jingrui Li |Li Wang |Yuqi Yang
Download Hi-Res ImageDownload to MS-PowerPointCite This:ACS Nano 2024, XXXX, XXX Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses).
-
Jun 9, 2023 |
frontiersin.org | Siqi Huang |Xiaojun Liu |Yuqi Yang |Haolong Li
1 IntroductionGastric cancer (GC) is the fifth most common cancer type and the third leading cause of death worldwide (1). The major risk factors for GC include Helicobacter pylori infection, age, high salt intake, and decreased intake of fruits and vegetables (2). Chronic H. pylori infection is the main reason for GC, accounting for approximately 89% of the distal GC cases worldwide (3). At present, >1 million people worldwide are newly diagnosed with GC each year.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →